Abstract

CorrigendumCorrigendum for Martínez-Rojas et al., volume 323, 2022, p. F425–F434Published Online:03 Feb 2023https://doi.org/10.1152/ajprenal.00099.2020_COROriginal articleMoreSectionsPDF (101 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat Martínez-Rojas MÁ, Sánchez-Navarro A, Mejia-Vilet JM, Pérez-Villalva R, Uribe N, Bobadilla NA. Urinary serpin-A3 is an early predictor of clinical response to therapy in patients with proliferative lupus nephritis. Am J Physiol Renal Physiol 323: F425 − F434, 2022. First published July 14, 2022. doi: 10.1152/ajprenal.00099.2022.In the disclosures section, “Programa de Doctorado en Ciencias Bioquímicas” should be “Programa de Doctorado en Ciencias Biomédicas.” Thus, the full disclosures section should read as follows:This study was performed in partial fulfillment of the requirements for a PhD degree; M.A.M.-R. is a doctoral student from the Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México, and received a fellowship from CONACYT (961986). No conflicts of interest, financial or otherwise, are declared by the authors.This article has no references to display. Download PDF Previous Back to Top FiguresReferencesRelatedInformation Related ArticlesUrinary serpin-A3 is an early predictor of clinical response to therapy in patients with proliferative lupus nephritis 14 Sep 2022American Journal of Physiology-Renal Physiology More from this issue > Volume 324Issue 2February 2023Pages F225-F225 Crossmark Copyright & PermissionsCopyright © 2023 the American Physiological Society.https://doi.org/10.1152/ajprenal.00099.2020_CORPubMed36734877History Published online 3 February 2023 Published in print 1 February 2023 Metrics

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call